Article

jdsupra.comjdsupra.com on 2023-12-15 23:51

Recent Biosimilar Approvals

On December 7, 2023, Bio-Thera Solutions, Ltd. announced that the FDA has approved AVZIVI (bevacizumab-tnjn), a biosimilar referencing Genentech’s ...

Related news